Found: 36
Select item for more details and to access through your institution.
Multi-detector computed tomography (MDCT)–based severity score as a prognostic tool in patients with suspected immune checkpoint inhibitor therapy associated colitis.
- Published in:
- European Radiology, 2021, v. 31, n. 12, p. 8868, doi. 10.1007/s00330-021-07925-7
- By:
- Publication type:
- Article
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. 563, doi. 10.1002/ajh.25448
- By:
- Publication type:
- Article
Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.871452
- By:
- Publication type:
- Article
Successful rechallenge with pembrolizumab after case of progressive immunotherapy‐related mucocutaneous eruption (PIRME), a Stevens‐Johnson syndrome‐like reaction.
- Published in:
- International Journal of Dermatology, 2023, v. 62, n. 10, p. 1292, doi. 10.1111/ijd.16572
- By:
- Publication type:
- Article
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Clinical features of acute kidney injury in patients receiving dabrafenib and trametinib.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 3, p. 507, doi. 10.1093/ndt/gfaa372
- By:
- Publication type:
- Article
Hyponatremia and other electrolyte abnormalities in patients receiving immune checkpoint inhibitors.
- Published in:
- Nephrology Dialysis Transplantation, 2021, v. 36, n. 12, p. 2241, doi. 10.1093/ndt/gfaa272
- By:
- Publication type:
- Article
Pre-Existing Autoimmune Disease and Mortality in Patients Treated with Anti-PD-1 and Anti-PD-L1 Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.
- Published in:
- Current Oncology Reports, 2020, v. 22, n. 4, p. 1, doi. 10.1007/s11912-020-0897-9
- By:
- Publication type:
- Article
The utility of procalcitonin for diagnosing bacteremia and bacterial pneumonia in hospitalized oncology patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5193, doi. 10.1007/s00432-022-04419-x
- By:
- Publication type:
- Article
Cost-effectiveness of Atezolizumab Combination Therapy for First-Line Treatment of Metastatic Nonsquamous Non–Small Cell Lung Cancer in the United States.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 9, p. e1911952, doi. 10.1001/jamanetworkopen.2019.11952
- By:
- Publication type:
- Article
A Rare Presentation of Aggressive Renal Cell Carcinoma and the Utility of Early Molecular Testing in Rapidly Progressing Malignancies: A Case Report.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. 1094, doi. 10.1093/oncolo/oyad280
- By:
- Publication type:
- Article
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e379, doi. 10.1093/oncolo/oyad001
- By:
- Publication type:
- Article
Temporal Trends in Inpatient Oncology Census Before and During the COVID‐19 Pandemic and Rates of Nosocomial COVID‐19 Among Patients with Cancer at a Large Academic Center.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. e1427, doi. 10.1002/onco.13807
- By:
- Publication type:
- Article
Impact of Cancer History on Outcomes Among Hospitalized Patients with COVID‐19.
- Published in:
- Oncologist, 2021, v. 26, n. 8, p. 685, doi. 10.1002/onco.13794
- By:
- Publication type:
- Article
Risk of COVID‐19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e898, doi. 10.1002/onco.13768
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient Setting.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 49, doi. 10.1002/onco.13561
- By:
- Publication type:
- Article
The Art of Oncology: COVID‐19 Era.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 997, doi. 10.1634/theoncologist.2020-0512
- By:
- Publication type:
- Article
Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e398, doi. 10.1634/theoncologist.2018-0883
- By:
- Publication type:
- Article
Diagnosis and Management of Rare Immune‐Related Adverse Events.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 6, doi. 10.1634/theoncologist.2019-0083
- By:
- Publication type:
- Article
Diagnosis and Management of Immune Checkpoint Inhibitor‐Associated Renal Toxicity: Illustrative Case and Review.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. 735, doi. 10.1634/theoncologist.2018-0764
- By:
- Publication type:
- Article
Diagnosis and Management of Immune Checkpoint Inhibitor‐Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 435, doi. 10.1634/theoncologist.2018-0359
- By:
- Publication type:
- Article
Colitis after checkpoint blockade: A retrospective cohort study of melanoma patients requiring admission for symptom control.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 4986, doi. 10.1002/cam4.2397
- By:
- Publication type:
- Article
Association of pre‐existing drug allergies with cutaneous immune‐related adverse events among patients on immune checkpoint inhibitor therapy.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 424, doi. 10.1111/bjd.21243
- By:
- Publication type:
- Article
Randomized trial of a hospice video educational tool for patients with advanced cancer and their caregivers.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A review of neurotoxicities associated with immunotherapy and a framework for evaluation.
- Published in:
- Neuro-Oncology Advances, 2021, v. 3, p. v108, doi. 10.1093/noajnl/vdab107
- By:
- Publication type:
- Article
Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the US.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2016144, doi. 10.1001/jamanetworkopen.2020.16144
- By:
- Publication type:
- Article
What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Decreased Absolute Lymphocyte Count and Increased Neutrophil/Lymphocyte Ratio With Immune Checkpoint Inhibitor-Associated Myocarditis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 9, p. 1058, doi. 10.1093/ced/llad180
- By:
- Publication type:
- Article
Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 7, p. e2321715, doi. 10.1001/jamanetworkopen.2023.21715
- By:
- Publication type:
- Article
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.
- Published in:
- JAMA Dermatology, 2022, v. 158, n. 8, p. 933, doi. 10.1001/jamadermatol.2022.1624
- By:
- Publication type:
- Article
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Patterns of Cutaneous and Noncutaneous Immune-Related Adverse Events Among Patients With Advanced Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Current Cardiology Reports, 2021, v. 23, n. 8, p. 1, doi. 10.1007/s11886-021-01530-2
- By:
- Publication type:
- Article